Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

MiMedx Group Q2 2024 Adj. EPS $0.08, Inline, Sales $87.207M Miss $88.919M Estimate

Author: Benzinga Newsdesk | July 31, 2024 04:11pm
MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. The company reported quarterly sales of $87.207 million which missed the analyst consensus estimate of $88.919 million by 1.93 percent. This is a 7.32 percent increase over sales of $81.257 million the same period last year.

Posted In: MDXG


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist